He assumed the position of executive vice president—Europe/Canada in May 2000, added the responsibilities for Africa/Middle East region as of January 2004 and responsibilities for Latin America in March 2006. He was named vice president of Pfizer in 2001 and promoted to president of worldwide pharmaceutical operations in 2006.
He took on the role of executive vice president—Europe/Canada in May 2000, then expanded his responsibilities to include Africa/Middle East in January 2004 and Latin America in March 2006. He was named vice president of Pfizer in 2001 and promoted to president of worldwide pharmaceutical operations in 2006.